Historical record - last NADAC effective date: 7/31/2015
Product Information
CARDIZEM CD 300 MG CAPSULE is a brand product labeled by Bausch Health US LLC, priced at $56.3495 per EA under NDC 00187079842. Its NADAC has been published 134 times since Jan 22, 2014.
FDA first approved this application on Dec 27, 1991. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the diltiazem hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Bausch Health US LLCNDC
00187079842
Classification
Brand
Dosage Form
CAPSULE, COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
7/31/2015
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020062FDA Approved
12/27/1991
TE Code
AB3
On Market Since
4/11/2001
Pharmacological Classes
Price Statistics
The NADAC for CARDIZEM CD 300 MG CAPSULE has been published 134 times since Jan 22, 2014, and over the history we have for it it has risen 235.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $56.3495 per EA |
|---|---|
| All-time high | $56.3495 (Aug 10, 2016) |
| All-time low | $16.8204 (Jan 22, 2014) |
| Median price | $42.6080 |
| Average price | $41.1166 |
| Largest weekly change | +30.0% (Oct 8, 2014) |
| Weeks tracked | 134 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+235.0%
Last surveyed Aug 10, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diltiazem hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARDIZEM CD 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CARDIZEM CD 300 MG CAPSULE, manufactured by Bausch Health US LLC, is $56.3495 per EA (NDC 00187079842), effective Aug 10, 2016.
How has the price of CARDIZEM CD 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CARDIZEM CD 300 MG CAPSULE has risen 235.0%. It has been tracked across 134 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CARDIZEM CD 300 MG CAPSULE?
Since Jan 22, 2014, the NADAC for CARDIZEM CD 300 MG CAPSULE has ranged from a low of $16.8204 (Jan 22, 2014) to a high of $56.3495 (Aug 10, 2016), with a median of $42.6080 per EA.
Are there cheaper alternatives to CARDIZEM CD 300 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIADYLT ER 300 MG CAPSULE, is $0.2616 per EA — about 99% below CARDIZEM CD 300 MG CAPSULE.
Who manufactures CARDIZEM CD 300 MG CAPSULE?
CARDIZEM CD 300 MG CAPSULE (NDC 00187079842) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.